Related Experiment Video
Updated: Apr 26, 2026
09:51
Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
Published on: January 29, 2015
16.4K
Neurobasal medium enhances titan cell formation in Cryptococcus spp
Juliana Godoy1, Igor Avellar-Moura1, Juliana Soares2
1Universidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Laboratório de Biofísica de Fungos, Rio de Janeiro, RJ, Brasil.
Memorias Do Instituto Oswaldo Cruz
|July 3, 2025
Summary
Neurobasal™ medium unexpectedly induces titan cell formation in Cryptococcus species. This simple method aids research into fungal pathogenesis and central nervous system infections.
Area of Science:
- Mycology
- Infectious Diseases
- Cell Biology
Background:
- Titan cells in Cryptococcus species are key to virulence, aiding resistance to oxidative stress, phagocytosis, and antifungal drugs.
- Understanding titan cell formation is vital for deciphering Cryptococcus pathogenesis.
Purpose of the Study:
- To report the discovery of a simple in vitro method for inducing titan cells in Cryptococcus neoformans and Cryptococcus gattii.
- To investigate the efficacy of Neurobasal™ (NB) medium for titan cell induction.
Main Methods:
- Utilized established in vitro culture techniques.
- Compared titan cell formation in Cryptococcus spp. grown in complete NB medium versus minimal medium (MM).
- Assessed the impact of the B27 supplement in NB medium on titan cell development.
Main Results:
- Complete NB medium significantly enhanced titan cell formation in Cryptococcus spp.
- Cells in NB medium showed larger cell bodies and increased capsule sizes.
- The absence of the B27 supplement in NB medium notably affected titan cell production.
Conclusions:
- Neurobasal™ medium is an effective tool for studying titan cell biology in Cryptococcus.
- The findings are relevant to understanding the role of titan cells in central nervous system infections caused by Cryptococcus.
Related Concept Videos
01:36Types of Toxins
3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
01:26Toxic Reactions: Overview
4.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
379
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
379
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:25Bioactivation and Tissue Toxicity
151
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
01:23Toxicity Testing in Animals
200
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
200